what are semaglutide drugs FDA warns about compounded versions of popular weight loss Demand Rising for 'Bootlegged' Weight-Loss
Description
AHA 2023 - Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) is interviewed by Dr Ahmed Ghoneem ( UPMC Harrisburg , US), CardioNerds Ambassador, on the findings of the SELECT Trial ( NCT03574597 )
doi:10.1056/NEJMoa2505928 Borlaug BA, Zile MR, Kramer CM, et al
Once-weekly 2.4 mg semaglutide for weight management in obesity: A game changer?touch
He questioned whether the elevated risk observed in the study might be short-lived
Other compounds work on the same machinery from a different angle, including mitochondrial peptides like MOTS-C
However, Ozempic is not approved for weight loss by the FDA, and the label does not disclose some common side effects, including Ozempic acid reflux
